Waddah Arafat

Waddah Arafat is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology. He serves as Medical Director of the Clinical Cancer Informatics Program at Harold C. Simmons Comprehensive Cancer Center, Chair of the Germ Cell Tumor Board, and Deputy Chief Medical Informatics Officer, with additional roles on the Quality Assurance & Performance Improvement Committee, Clinical Oversight Committee, and Oncology Care Model Steering Committee.

Education:

• Medical Degree: Damascus University Faculty of Medicine (Damascus, Syria)
• Residency: Indiana University School of Medicine (Indianapolis)
• Fellowship: University of Wisconsin (Madison) in Hematology and Medical Oncology

Dr. Arafat's research centers on clinical and radiation oncology with specialized expertise in germ cell tumors, urothelial cancer, and renal cell carcinoma. His work integrates cancer informatics to address healthcare disparities and optimize treatment protocols, particularly in stereotactic ablative radiotherapy and circulating tumor cell biomarker development. Current investigations focus on improving outcomes for underserved populations in testicular cancer care and advancing precision medicine approaches for kidney cancer.

His 12 publications (2014-2021) reveal a consistent focus on renal cell carcinoma management, germ cell tumor relapse patterns, and urothelial cancer biomarkers. Key trends include stereotactic radiation for oligometastatic disease, telemedicine implementation in oncology, and socioeconomic disparities in cancer care access. His research frequently involves multi-institutional clinical trials and collaborative biomarker validation studies.

Dr. Arafat actively contributes to quality improvement through Simmons Comprehensive Cancer Center committees, emphasizing clinical oversight and performance metrics. He is certified by the American Board of Internal Medicine in hematology and medical oncology and maintains active membership in the American Society of Clinical Oncology.